A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
Phase 2 Completed
19 enrolled 11 charts
Molecular-Guided Therapy for Childhood Cancer
Phase NA Completed
186 enrolled 12 charts
Multi-Arm Study to Test the Efficacy of Immunotherapeutic Agents in Multiple Sarcoma Subtypes
Phase 2 Completed
57 enrolled 18 charts
METZOLIMOS
Phase 1 Completed
23 enrolled 15 charts
STIR
Phase 2 Terminated
15 enrolled 11 charts
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase 2 Completed
78 enrolled 11 charts
Osteosarcoma
Phase 2 Completed
32 enrolled 11 charts
18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma
Phase 2 Terminated
1 enrolled 5 charts
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Phase 2 Completed
131 enrolled 22 charts
A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma
Phase 2 Completed
43 enrolled 25 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
M6620 (VX-970) in Selected Solid Tumors
Phase 2 Completed
30 enrolled 15 charts
Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Phase 2 Completed
178 enrolled 16 charts
LVPK
Phase 1 Completed
20 enrolled 9 charts
Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Phase 3 Completed
6 enrolled 2 charts
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma
Phase 1/2 Completed
18 enrolled 11 charts
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Phase 3 Terminated
23 enrolled 9 charts
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Phase 2 Completed
13 enrolled 15 charts
Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
Phase 2 Completed
11 enrolled 6 charts
A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Phase 2 Terminated
38 enrolled 10 charts
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Phase 2 Terminated
4 enrolled 9 charts
MEMOS
Phase 2 Terminated
8 enrolled 17 charts
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Phase 1/2 Completed
24 enrolled 14 charts
Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
Phase 2 Terminated
9 enrolled 13 charts
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Phase 2 Completed
20 enrolled 10 charts
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Phase 2 Completed
53 enrolled 6 charts
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Phase 2 Completed
40 enrolled 6 charts
Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
Phase 2 Completed
22 enrolled 6 charts
OCR
Phase 2 Completed
49 enrolled 7 charts
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Phase 3 Terminated
22 enrolled 9 charts
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
Phase 2 Terminated
7 enrolled 7 charts
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
Phase NA Terminated
7 enrolled 3 charts
Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
Phase 2 Terminated
7 enrolled 2 charts
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2 Completed
54 enrolled 8 charts